- Home
- GDS vs HALO Comparison
GDS vs HALO Comparison
Compare GDS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDS
- HALO
- Stock Information
- Founded
- GDS 2001
- HALO 1998
- Country
- GDS China
- HALO United States
- Employees
- GDS N/A
- HALO N/A
- Industry
- GDS Computer Software: Programming Data Processing
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GDS Technology
- HALO Health Care
- Exchange
- GDS Nasdaq
- HALO Nasdaq
- Market Cap
- GDS 7.4B
- HALO 7.6B
- IPO Year
- GDS 2016
- HALO N/A
- Fundamental
- Price
- GDS $33.38
- HALO $66.98
- Analyst Decision
- GDS Strong Buy
- HALO Buy
- Analyst Count
- GDS 7
- HALO 11
- Target Price
- GDS $47.51
- HALO $73.09
- AVG Volume (30 Days)
- GDS 3.1M
- HALO 2.4M
- Earning Date
- GDS 11-18-2025
- HALO 11-04-2025
- Dividend Yield
- GDS N/A
- HALO N/A
- EPS Growth
- GDS N/A
- HALO 68.93
- EPS
- GDS 3.46
- HALO 4.37
- Revenue
- GDS $1,526,241,101.00
- HALO $1,178,672,000.00
- Revenue This Year
- GDS $13.40
- HALO $32.57
- Revenue Next Year
- GDS $14.16
- HALO $23.77
- P/E Ratio
- GDS $162.61
- HALO $15.32
- Revenue Growth
- GDS 10.29
- HALO 34.97
- 52 Week Low
- GDS $16.93
- HALO $42.01
- 52 Week High
- GDS $52.50
- HALO $79.50
- Technical
- Relative Strength Index (RSI)
- GDS 40.78
- HALO 41.55
- Support Level
- GDS $33.14
- HALO $63.80
- Resistance Level
- GDS $35.02
- HALO $68.00
- Average True Range (ATR)
- GDS 2.03
- HALO 2.26
- MACD
- GDS -0.87
- HALO -0.66
- Stochastic Oscillator
- GDS 2.23
- HALO 25.44
About GDS GDS Holdings Limited ADS
GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia via the now 38% owned DayOne. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.